Glioblastoma multiforme

1. Gene symbol

 

Overall survival at 16 months (n=454)

3. Treatment

Any chemotherapy

Angiogenesis inhibitor

Bevacizumab

Carmustine

Irinotecan

Lomustine

Nitrosoureas

Temozolomide

Topoisomerase inhibitor

Total: 0

Non-responders: 0

Responders: 0

4. Filters (optional)

Radiotherapy All no (n = 39) yes (n = 415)

Gender status All Male (n = 298) Female (n = 156)

5. Settings

JetSet only

No outliers

Show quartiles

Multi-gene analysis

Color: non-responder

Color: responder

ROC curve color

Calculate

By using the services, you agree to be bound by the Terms of Use.

Please kindly cite our paper to support further development: Fekete J & Gyorffy B: ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients, Int J Cancer, 2019 Dec 1;145(11):3140-3151.,doi: 10.1002/ijc.32369.